Cell Competition: Pirates on the Tangled Bank  by Green, Douglas R.
Cell Stem Cell
PreviewsCell Competition: Pirates on the Tangled BankDouglas R. Green1,*
1St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
*Correspondence: douglas.green@stjude.org
DOI 10.1016/j.stem.2010.03.006
Competition by stem cells for occupation of a limited niche is a well-described phenomenon. Two recent
studies highlight competition between hematopoietic stem cells based on p53. These findings have implica-
tions for both normal homeostasis and tumorigenesis.The conventional view of development at
the cellular level is somewhat like a ship
in the 18th century royal navy, with hierar-
chical levels of command, rigidly followed
by a loyal crew that function as trained
units to perform duties to the benefit of
the whole. But an emerging view suggests
an analogy more akin to a pirate ship,
where competition, cheating, and the
struggle for dominance seethes below
the superficially harmonious deck. In
certain circumstances, cells compete for
occupation of limited niches, and fitness
or dominance determines which of the
cells prevail.
Two recent papers from Bondar and
Medzhitov (2010) (this issue of Cell Stem
Cell) and Marusyk et al. (2010) provide
insight into a form of cell competition
that occurs in mammalian hematopoietic
stem cells (HSCs). Both sets of authors
used hematopoietic reconstitution of
lethally irradiated animals to test HSC
properties. Normally, if two marked popu-
lations of HSCs are mixed, they reconsti-
tute the hematopoietic lineages in line
with their starting ratios. However, both
sets of authors found that mild DNA
damage to one population (at a level that
still permits reconstitution if this popula-
tion is introduced alone) compromises
its ability to compete with an untreated
population when these are mixed. This
loss of competitive fitness is dependent
upon the function of p53, and irradiated
p53+/ or p53/ HSCs outcompete irra-
diated WT HSCs. The effect does not
require DNA damage per se; cells that
are heterozygous for a null allele of the
p53 inhibitor, MDM2, are outcompeted
by wild-type cells without a need for irra-
diation of the population (Bondar and
Medzhitov, 2010). Thus, it appears to be
the levels of p53 protein that determine
the fitness of a cell in this competitive
scenario. ‘‘Winners’’ are cells that expresslower levels of p53 whereas ‘‘losers’’
express higher levels, irrespective of the
damage they have received. Normally, of
course, the level of p53 would reflect the
extent of damage, and thus this competi-
tion would ensure that the least damaged
cells populate the niche. However,
winners do more than simply proliferate
more rapidly than losers; both popula-
tions respond to the competition and
thereby contribute to the outcome. That
is, the patterns of gene expression in
each population change depending on
whether or not the cells are in competi-
tion: winners and losers sense each
other’s presence.
Cell competition has been character-
ized in other many organisms and settings
(Johnston, 2009), and other examples of
such ‘‘sensing’’ are known. For example,
in the wing imaginal disk, cells with
increased ribosomal function are relative
winners, and again the cells appear to
respond to the status of their competitors.
In both this example and in mammalian
HSCs, it is assumed that the competition
is essentially cooperative; losers promote
winners while winners suppress losers
(Figure 1). One mechanism for such coop-
eration is compensatory proliferation, in
which the engagement of apoptotic path-
ways in the losers results in their produc-
tion of growth signals for neighboring
cells. InDrosophila, this effect is mediated
by production of TGF and Wnt family
mediators in the dying losers (Ryoo
et al., 2004). In mammalian tissues, dying
cells produce lipid and eicosinoid media-
tors that signal expansion of stem cells
in various tissues (Li et al., 2010). How-
ever, in the HSC competition mediated
by p53, cell death by the losers does not
appear to be a major factor in the success
of winners (Bondar and Medzhitov, 2010).
Nevertheless, in this case competition
at the cellular level appears to work forCell Stem Cbenefit at an organismal level, because
the fittest (least damaged) stem cells
prevail.
But there is a potential problem with
this view, which brings us back to our
pirate scenario—the problem of
‘‘cheaters.’’ In the case of HSCs, cells
with a lower p53 level win the competition,
but low levels of p53 can also be pro-
duced by mutation. Cells with defective
p53 function can therefore dominate the
niche, and, when they do, the potential
for a hypercompetitive neoplasia severely
compromises organismal fitness (Maru-
syk et al., 2010). Therefore, it is possible
that an additional mechanism exists to
detect such cheaters and limit their
inherent advantages (Figure 1B).
The concept of cheaters in cell com-
petition has been explored in another
scenario. One of the first studies of
cellular competition (Buss, 1982) identi-
fied natural mutants of Dictostelium that
cannot produce the stalk of the fruiting
body. Because these altruistic stalks are
required for dispersal of spores, the
mutants are dependent on their wild-
type counterparts in the aggregate and
display a competitive advantage in spore
differentiation. As long as the mutant cells
are present in relatively low numbers, they
increase to a stable level in the aggre-
gates. However, if they are present at
a higher frequency, their intrinsic compet-
itive advantage results in stalkless (and
therefore reproductively dead) individ-
uals. This undesirable scenario appears
to have favored the emergence of resis-
tance mechanisms that limit incorporation
of such cheaters into colonies. One form
this resistance takes is in fusion/rejection
mechanisms that exist throughout colo-
nial organisms, in addition to other mech-
anisms (Buss, 1982; Khare et al., 2009).
Do similar mechanisms exist to limit the
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Figure 1. Cellular Competition Models
(A) Cell competition in HSCs based on p53 level. After mild DNA damage, cells
with less p53 protein emerge as ‘‘winners’’ when in competition with cells
sustaining higher levels of p53. In this model, the cells destined to be winners
(smiling) actively inhibit those that will be losers (frowning), while the losers
actively promote the winners (Bondar and Medzhitov, 2010; Marusyk et al.,
2010). This model is also supported by p53-independent cell competition in
other systems (Johnston, 2009).
(B) Hypothetical competition in HSCs including cheater resistance. If cells
‘‘cheat’’ by mutating p53 (eyepatch), mechanisms may exist to reduce their
intrinsic competitive advantage (feedback circles). One hypothetical mecha-
nism is shown: Cells with high p53 express extrinsic proteins that inhibit neigh-
boring cells, whereas low-level tonic p53 may create resistance to this inhibi-
tion. Cells with loss of p53 do not have this competitive advantage and thus
do not effectively cheat.
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We know that repeated
rounds of damage and regen-
eration predispose for onco-
genesis, and a competitive
advantage of cells with
defective p53 can explain
this effect. But the lag times
and clonal nature of tumors
induced in such cancer
models suggest that resis-
tance mechanisms may
indeed act to limit such
cheating. If so, what form
might such mechanisms
take? It is possible, for ex-
ample, that cells that lose
p53 may be less intrinsically
fit than cells that retain p53
but do not activate it. Tonic,
low-level p53 function may
help to sustain some meta-
bolic processes (Vousden
and Ryan, 2009), including
autophagy (Amaravadi et al.,
2007), that can give wild-
type cells a short-term
advantage over p53-deficient
cheaters under some circum-
stances. As noted by Bondar
and Medzhitov (2010), p53
induces a number of extrinsic
mediators, including cyto-
kines and growth factors,
that can stimulate HSC prolif-
eration and survival. How-
ever, other p53 targets can
extrinsically inhibit growth,including IGF-binding protein and galec-
tin-7 (also known as p53-inducible
gene-1). Indeed, we do not know whether
any of the altered gene expression
observed in losers and winners under
competition might represent a mechanism
of cheater recognition and resistance.
Moreover, although we know that mutant
cheaters win against irradiated wild-type
losers, they may themselves lose to
wild-type cells that have not sustained
damage (this scenario was not tested).
One way this could occur is illustrated in
Figure 1B.288 Cell Stem Cell 6, April 2, 2010 ª2010 ElsWithout such cheater resistance, the
emergence of p53 mutant cells would be
inevitable whenever p53 is engaged and
competition occurs, and thus the precan-
cerous state would be marked by such
mutants. However, p53 mutation tends
to be a later event, generally after onco-
gene activation en route to cancer.
Instead, competition favoring the least
damaged stem cells postpones the con-
ditions of aging (which are accelerated
by p53). Competition among progenitor
cells thus represents a case of a conflict
between the units of selection (cellsevier Inc.versus organisms) and the
mechanisms that may work
to resolve this conflict (such
as cheater resistance) there-
fore have consequences
that impact on matters of
clinical importance. Whether
such mechanisms do, in
fact, exist in our own cells,
and how they work, are
ongoing issues.
Darwin imagined, in his last
paragraph of the Origin of
Species, a tangled bank of
competing organisms, and it
now seems that we can
stretch his analogy to the
dynamic interactions of cells
that populate niches during
development and repair.
Although pirates may lurk
among the foliage, we will
have to see whether their
cheating ways are always
victorious or whether some
measure of law is enforced
on this wild frontier.
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